Category: Market News

EssilorLuxottica (EU:EL) has taken over Faro, an Italian firm focused on high-precision CNC machinery used in the production of eyewear frames and lenses, reinforcing its vertically integrated business model.

The Italian-French eyewear group did not disclose the financial terms of the transaction.

Faro, headquartered in Santa Maria di Sala near Venice, brings more than two decades of experience in developing, producing, and supplying hardware and software solutions for both the eyewear and jewelry sectors.

EssilorLuxottica said the acquisition “will allow us to further expand our portfolio of manufacturing expertise and capabilities and accelerate the development of innovative machines for the production of frames and lenses for the entire industry.”

Renault (EU:RNO) delivered a stronger-than-anticipated first quarter, with revenue rising 8.8% at constant exchange rates to €12.53 billion ($14.67 billion), comfortably above analyst expectations of €11.57 billion.

Growth was primarily driven by the automotive division, where revenue increased 8% on a constant-currency basis to €10.81 billion.

Vehicle sales rose 3.8% across Europe and 2.2% globally.

The performance comes amid a more uncertain macro backdrop. Renault said it is “taking additional measures to mitigate the potential impact of the Middle East crisis on raw materials, energy, and logistics costs.”

The group sold 546,183 vehicles during the quarter, representing a 3.3% decline compared with the same period last year. The drop was mainly linked to temporary factors affecting Dacia, while sales at Renault and Alpine recorded growth.

“In the first quarter of 2026, despite a challenging start of the year in registrations due to one-off factors at Dacia, we are benefiting from a robust product momentum across all our brands, for both passenger cars and light commercial vehicles,” said Renault CFO Duncan Minto.

“This positive momentum is underpinned by a double-digit order intake since the start of the year.”

Despite these challenges, the French automaker maintained its full-year outlook, targeting an operating margin of around 5.5% of group revenue and automotive free cash flow of roughly €1 billion.

Shares of Orange (EU:ORA) moved higher on Thursday after the French telecom operator upgraded its full-year earnings guidance and delivered first-quarter results that exceeded expectations.

The company now expects earnings before interest, taxes, depreciation, and amortization after leases—a key measure of performance in the telecom sector—to increase by more than 3% this year. Previously, Orange had projected growth of around 3%.

First-quarter revenue was supported by strong momentum in the Middle East and Africa, along with stable contributions from its core European markets. Group revenue rose 3.5% year-on-year to €10.1 billion.

In France, its largest market, revenue increased 2.3% to €4.4 billion, driven by the addition of 54,000 fixed broadband customers and 40,000 mobile users. The company continues to phase out its legacy copper network and is progressing with the shutdown of its 2G infrastructure in the country.

Orange Cyberdefense, the group’s cybersecurity arm seen as a key growth driver, recorded a 9.2% increase in revenue.

Core earnings after leases rose 6.6% to €2.60 billion, surpassing analyst expectations of €2.58 billion. Capital expenditure for the quarter totaled €1.54 billion, broadly in line with forecasts.

Man Group (LSE:EMG) reported assets under management of $228.7 billion for the first quarter, coming in about 1% below analyst expectations of $231.3 billion, as the firm recorded net outflows of $1.6 billion compared with forecasts for $1.8 billion in inflows.

The asset manager experienced withdrawals across both its Alternatives and Long-Only businesses, with net outflows of $1.0 billion and $0.6 billion, respectively.

In the Alternatives segment, Absolute Return strategies saw $1.1 billion in outflows, while Multi-Manager products recorded $0.8 billion in redemptions. These were partly offset by $0.9 billion of inflows into Total Return strategies.

Within Long-Only, Discretionary strategies brought in $2.6 billion of new money, but Systematic Long-Only strategies faced $3.2 billion in outflows.

The decline in Systematic Long-Only assets was largely driven by a single client withdrawing roughly $6 billion. The company said this move reflected an asset allocation decision rather than dissatisfaction with performance. Excluding this redemption, Long-Only flows would have been positive overall.

By the end of the period, Alternatives assets stood at $106.4 billion, including $44.1 billion in Absolute Return, $48.3 billion in Total Return, and $14.0 billion in Multi-Manager strategies. Long-Only assets totaled $122.3 billion, with $72.4 billion in Systematic strategies and $49.9 billion in Discretionary mandates.

Investment gains added $3.1 billion to AUM during the quarter, while foreign exchange movements and other factors reduced assets by $0.4 billion.

At a strategy level, Solutions and Risk Premia saw increases of $1.6 billion and $0.8 billion, respectively, while Private Credit assets rose by $0.5 billion.

Elsewhere, Discretionary Long-Only Equity and Long-Only Credit expanded by $0.5 billion and $1.6 billion, respectively. Systematic Long-Only Equity assets fell by $4.1 billion, reflecting the impact of the large client redemption.

More about Man Group

Man Group is a global investment management firm specializing in alternative and long-only strategies. The company offers a wide range of solutions across asset classes, including equities, credit, multi-asset, and private markets, serving institutional and retail investors worldwide.

Connecting Excellence Group Plc (AQSE:XCE) (USOTC:XCELF) has secured additional investment from strategic backer Adam Back, while also increasing its Bitcoin holdings as part of its treasury strategy.

The company confirmed that Adam Back has agreed to subscribe for 33,457,143 new ordinary shares at 1.75 pence per share, matching the closing mid-price on 22 April 2026. The subscription will raise gross proceeds of £585,500, which will be directed toward expanding the group’s Bitcoin treasury.

Following admission of the new shares, Connecting Excellence will have 415,622,830 ordinary shares in issue, each carrying one voting right.

Scott Ellam, Chief Executive Officer of Connecting Excellence Group, commented: “It’s a privilege to have Adam Back as a strategic investor in XCE. He is one of the leading figures in the history of Bitcoin so we are delighted that he has increased his investment and support for our ongoing strategy.

“Since we embarked on our journey from the first BTC purchase as a private company in 2021, to one of the first listed operational businesses with an integrated BTC treasury at the end of 2025, we have continued to grow our executive recruitment operations in conjunction with the expansion of our BTC balance sheet. We look forward to providing further updates on our progress to the market.”

Bitcoin Purchase Lifts Treasury Holdings

Alongside the fundraising, the company announced it has purchased 10 Bitcoin for a total of £585,000. This brings its total holdings to 62.941 Bitcoin, valued at £3,685,196.33, reinforcing its commitment to a Bitcoin-focused treasury model.

Strategy Combines Recruitment Growth with Bitcoin Treasury

Connecting Excellence positions itself as an international executive recruitment group with a long-term Bitcoin treasury strategy. Its core business, Spencer Riley, specialises in placing senior executives across high-growth sectors including engineering, logistics, life sciences, automation, technology, and professional services.

The company aims to align its recruitment growth with its Bitcoin strategy, using performance-based incentives and equity structures to attract talent, drive revenue, and support expansion. It is also developing a dedicated Bitcoin-focused recruitment division to connect executives with opportunities in both Bitcoin-native companies and traditional businesses seeking digital asset expertise.

Hikma Pharmaceuticals (LSE:HIK) maintained its full-year 2026 outlook following a strong performance across its Injectables, Branded, and Hikma Rx divisions. The group expects revenue growth of 2% to 4% and operating profit in the range of $720 million to $770 million, supported by solid demand, recent product launches, and increased manufacturing capacity. Margins are expected to remain stable across all divisions, while the company continues to wind down its non-core 503B compounding operations.

Inhalation Strategy and Product Development Progress

Management highlighted ongoing advancements in its complex inhalation portfolio, including a new device partnership aimed at accelerating its generic Ellipta programme. Continued contributions from products such as generic Advair Diskus also reflect the company’s growing presence in differentiated respiratory treatments. Alongside these developments, Hikma reaffirmed its commitment to shareholder returns, announcing a 5% increase in its total dividend for 2025 and continuing its share buyback programme of up to $250 million, while remaining mindful of geopolitical risks in the Middle East and rising logistics and energy costs.

Outlook Balanced by Cash Flow and Market Signals

The company’s outlook is tempered by softer cash generation and a bearish technical trend, with the stock trading below key moving averages and showing oversold conditions. However, these challenges are partly offset by an attractive valuation, including a relatively low price-to-earnings ratio and a strong dividend yield. Management’s positive earnings guidance and ongoing capital return programme provide additional support, despite near-term pressures in the injectables segment.

More about Hikma Pharmaceuticals

Hikma Pharmaceuticals is a UK-based multinational pharmaceutical company focused on developing, manufacturing, and marketing a wide range of branded and generic medicines. With operations spanning North America, the Middle East and North Africa, and Europe, the group specialises in injectables, branded treatments, and prescription generics, supported by strong manufacturing capabilities, licensing partnerships, and expertise in inhalation technologies.

Carclo (LSE:CAR) said trading for the year ended 31 March 2026 met expectations, with revenue of around £114 million compared with £121 million in the previous year, reflecting its continued exit from lower-margin, short-run contracts. Despite the decline in sales, the group delivered strong growth in EBIT and achieved its medium-term targets for return on sales and return on capital employed ahead of schedule. Net debt remained broadly stable at approximately £24 million.

Operational Improvements and Strategic Focus

Management highlighted the completion of a multi-year turnaround, marked by significantly improved margins and a clearer focus on regulated end markets such as life sciences and aerospace. Operational efficiencies were also driven by the consolidation of US operations and capacity expansion across Europe and China. The Speciality division recorded double-digit revenue growth, supported by strong demand in aerospace. Entering FY27, the group expects continued momentum across both divisions and is preparing to launch its “Precision 2030” growth strategy, aimed at driving higher-margin expansion despite ongoing geopolitical cost pressures.

Outlook Weighed by Financial and Market Concerns

While recent performance and strategic progress have improved sentiment, Carclo’s outlook remains affected by financial instability and bearish technical indicators. Although management commentary and corporate developments suggest growing confidence, valuation concerns and underlying financial risks continue to weigh on the overall investment case.

More about Carclo plc

Carclo plc is a global precision engineering company specialising in the design, development, and manufacture of high-reliability components and systems. It serves markets including life sciences, aerospace, and safety and security, with a focus on regionalised production. The company is listed on the Main Market of the London Stock Exchange.

Chill Brands Group (LSE:CHLL) reported continued progress within its Chill Connect distribution business, which has broadened its product offering beyond vaping and nicotine alternatives to include beverages, confectionery, batteries, and other fast-moving consumer goods. The company is also finalising development of a new wholesale digital ordering platform for convenience retailers, designed to simplify purchasing, reduce reliance on cash transactions, and expand its reach across the fragmented independent retail sector.

Digital Strategy and chill.com Platform Potential

In parallel with its distribution growth, the group is evaluating the strategic potential of its premium chill.com domain as the foundation for a broader digital platform ecosystem. With limited internal resources, Chill Brands has entered early-stage discussions with experienced third-party operators about licensing complementary marketplace, social, and financing platforms. These would be developed and managed externally, although discussions remain preliminary, with no binding agreements in place and no certainty that a deal will be completed.

Financial Challenges and Market Signals

The company’s outlook is weighed down by weak financial performance, including negative gross profit, significant losses, ongoing cash burn, and a balance sheet showing negative equity alongside debt. Technical indicators provide only limited short-term support and remain weak over a longer horizon, with negative momentum signals. Valuation offers little support given the absence of earnings and no dividend yield.

More about Chill Brands Group PLC

Chill Brands Group plc is a UK-based consumer packaged goods company focused on distribution within the convenience retail sector. Through its Chill Connect platform, the group operates a national field sales network providing direct-to-store distribution and advisory services. Its portfolio spans categories such as vaping, nicotine alternatives, beverages, confectionery, and other everyday consumer products.